- Forums
- ASX - By Stock
- BGT
- Ann: Bio-Gene Extends Commercial Development Agreement
Ann: Bio-Gene Extends Commercial Development Agreement, page-9
Featured News
Add BGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.06M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 5.0¢ | $10 | 197 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 84318 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 83647 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 84318 | 0.047 |
1 | 10763 | 0.046 |
1 | 96000 | 0.044 |
1 | 33333 | 0.043 |
2 | 27375 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 83647 | 2 |
0.061 | 10103 | 1 |
0.063 | 10761 | 1 |
0.071 | 57400 | 1 |
0.073 | 8685 | 1 |
Last trade - 09.59am 13/11/2024 (20 minute delay) ? |
Featured News
BGT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online